𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER update

✍ Scribed by McNeil, Dawn Elizabeth ;Coté, Timothy R. ;Clegg, Limin ;Rorke, Lucy Balian

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
163 KB
Volume
39
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

It has been suggested that cerebellar medulloblastoma (m) and primitive neuroectodermal tumors (pnet) arising elsewhere in the nervous system, represent a single entity (m/pnet), although this concept is controversial. cancer registries permit population-based description of cases reported as medulloblastoma, those reported as pnet and description of the aggregate, m/pnet.

Procedure:

We reviewed the 768 cases of m/pnet (633 diagnosed medulloblastoma and 135 diagnosed pnet) among persons under 20 years of age in the national cancer institute's surveillance epidemiology and end results (seer) database.

Results:

The incidence of m/pnet rose 23%, from 4 per 10(6) person-years in 1973-77 to 4.9 per 10(6) person-years in 1993-98. cases reported as pnet were more likely than those reported as medulloblastoma to be supratentorial (30.4% vs. 1.9%, p < 0.001) and to be female (42.2% vs. 35.4%, p = 0.13). the difference in 5-year survival between the 600 children with infratentorial medulloblastoma vs. the 49 children with infratentorial pnet was not statistically significant (55% vs. 43%). regardless of reporting diagnosis, survival was poorer among children age 0-3 years and those with supratentorial tumors. children diagnosed in the more recent period from 1985-1998 had a longer median survival than children diagnosed in 1973-84 (4.9 years vs. 10 years, p < 0.05). rates were 42% higher among whites compared to blacks (4.5/10(6) person-years vs. 3.1/10(6) person-years, p < 0.01).

Conclusions:

We found m/pnet is increasing in incidence and more frequent among whites. given that medulloblastoma and pnet are histologically identical and have similar epidemiologic profiles, future studies should provide analyses that combine these entities.

📜 SIMILAR VOLUMES

SEER update of incidence and trends in p
SEER update of incidence and trends in pediatric malignancies: Acute lymphoblastic leukemia
✍ Davies, Stella M. ;Ross, Julie A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

for socio-economic factors and the improvement in outcomes in the recent era may reflect better characterization of leukemia and therapy assignment [4,5]. There remains a need for a large-scale assessment of pharmacogenetic polymorphism that might influence outcome of therapy, and such a study is un

SEER update of incidence and trends in p
SEER update of incidence and trends in pediatric malignancies: Acute lymphoblastic leukemia
✍ McNeil, Dawn Elizabeth ;Coté, Timothy R. ;Clegg, Limin ;Mauer, Alvin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract ## Background Acute lymphoblastic leukemia (ALL) represents the most common malignancy of childhood. Its incidence peaks in children just before school entry age; i.e., in 2–3 year olds. It is known to be more common in white children in the USA; the incidence is also higher in boys th

Thyroid dysfunction as a late effect in
Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/Primitive neuroectodermal tumors : A comparison of hyperfractionated versus conventional radiotherapy
✍ Daisy Chin; Charles Sklar; Bernadine Donahue; Naveen Uli; Nancy Geneiser; Jeffre 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Background: Primary hypothyroidism is a common sequela of craniospinal radiotherapy in the treatment of pediatric brain tumors. ## Methods: The authors compared the incidence of primary hypothyroidism after hyperfractionated radiotherapy (hfrt) (n = 14 patients) versus conventionally fractiona

No preferential parent of origin for the
No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma)
✍ Jaclyn A. Biegel; Erica Wentz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

We have shown that an i(17q) is the most frequent abnormality in central nervous system primitive neuroectodermal tumors (PNETs; medulloblastoma), implicating the presence of a tumor suppressor gene which maps to 17p. In the present study, we investigated whether the deletion of chromosome arm 17p t

A phase II study of the farnesyl transfe
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: A children's oncology group study
✍ Maryam Fouladi; H. Stacy Nicholson; Tianni Zhou; Fred Laningham; Kathleen J. Hel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## BACKGROUND. An open‐label Phase II study of tipifarnib was conducted to evaluate its safety and efficacy in children with recurrent or refractory medulloblastoma (MB)/primitive neuroectodermal tumor (PNET), high‐grade glioma (HGG), and diffuse intrinsic brainstem glioma (BSG). ## M